Metal abstraction peptide (MAP) tag and associated methods
AssigneeUniversity of Kansas
InventorsJennifer Ann Stowell Laurence, Anthony Andrew Vartia, Mary Elizabeth Krause
Life of this patent
Estimating the term…
Abstract
Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.
Claims31
A composition comprising:
- (a) a tripeptide having a sequence XC1C2,
- wherein X is any natural or non-natural amino acid or amino acid analog,
- and further wherein C1 and C2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid;
- and
- (b) a metal atom or ion bound to the sequence XC1C2,
- wherein the metal atom or ion is bound in a square planar or square pyramidal orientation.
A method of preparing a metal-peptide complex comprising:
- i) exposing a metal atom or ion to a chelating agent in solution or on a solid support;
- and
- ii) binding a peptide including the sequence XC1C2 with the metal atom or ion to form a metal-XC1C2 complex;
- wherein X is any non-cysteine amino acid;
- and wherein C1 and C2 are the same or different;
- and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like normatural amino acid;
- wherein said metal atom or ion is bound within the sequence XC1C2 in a square planar orientation or square pyramidal orientation;
- and
- wherein said chelating agent is linked to a solid support.
A method of preparing a metal-peptide complex comprising:
- i) exposing a metal atom or ion to a chelating agent in solution or on a solid support;
- and
- ii) binding a peptide including the sequence XC1C2 with the metal atom or ion to form a metal-XC1C2 complex;
- wherein X is any non-cysteine amino acid;
- and wherein C1 and C2 are the same or different;
- and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like normatural amino acid;
- wherein said metal atom or ion is bound within the sequence XC1C2 in a square planar orientation or square pyramidal orientation;
- and
- wherein said chelating agent is selected from the group consisting of iminodiacetic acid (IDA) and nitrilotriacetic acid (NTA).
Dependencies are inferred from the claim text.